Anavex Life Sciences (AVXL) Sinks on 2-73 Abstract Update

Go back to Anavex Life Sciences (AVXL) Sinks on 2-73 Abstract Update

Anavex Life Sciences Corp. (AVXL) Taps Session Low

November 9, 2015 2:58 PM EST

Anavex Life Sciences Corp. (NASDAQ: AVXL) shares hit session lows Monday afternoon, falling 25%. The stock began the day higher after the company presented positive safety and cognitive efficacy data for ANAVEX 2-73, its investigational oral treatment for Alzheimers disease, at the CTAD 2015... More

Anavex Life Sciences (AVXL) Gains as Phase 2a Trial of ANAVEX 2-73 Met Endpoints

November 9, 2015 8:38 AM EST

Anavex Life Sciences Corp. (NASDAQ: AVXL) is trading up 19% in pre-open trade Monday after the company announced that on Saturday, investigators presented positive safety and cognitive efficacy data for ANAVEX 2-73, the Companys lead investigational oral treatment for Alzheimers disease targeting sigma-1 and muscarinic receptors, which are believed to reduce protein misfolding... More

Anavex Life Sciences (AVXL) Mentioned as Short

November 6, 2015 1:43 PM EST

Anavex Life Sciences Corp. (NASDAQ: AVXL) was mentioned as a short by Martin Shkreli.

I shorted $AVXL - i do not believe the drug *can* work given its PK and receptor pharmacology profile.

Martin Shkreli (@MartinShkreli) November 6, 2015


... More